Stanford University Department of Surgery - Company Presentation

Presented by: Jill Helms, D.D.S., Ph.D., Professor, Department of Surgery Dr. Jill Helms is actively working with a disease team on a WNT-based therapy targeting endogenous stem cells to enhance skeletal healing in the elderly. WNT proteins are naturally-occurring signaling molecules that guide stem cell fate and tissue regeneration. The therapeutic potential of WNT proteins has been recognized for years but challenges in manufacturing, formulation, and delivery have hindered their development as drug candidates. Our technology addresses these obstacles and we have accrued strong proof-of-concept data that a WNT-based approach is broadly effective at activating endogenous stem cells for tissue regeneration, especially in elderly patients. For more information on the 2013 Stem Cell Meeting on the Mesa visit www.stemcellmeetingonthemesa.com